XML 41 R26.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

(LOSS) EARNINGS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2019
Earnings Per Share [Abstract] |
(LOSS) EARNINGS PER SHARE | (LOSS) EARNINGS PER SHARE (Loss) earnings per share attributable to Bausch Health Companies Inc. for 2019, 2018 and 2017 were calculated as follows:
(in millions, except per share amounts) |  | 2019 |  | 2018 |  | 2017
Net (loss) income attributable to Bausch Health Companies Inc. |  | $ | (1,788 | ) |  | $ | (4,148 | ) |  | $ | 2,404 |
Basic weighted-average number of common shares outstanding |  | 352.1 |  |  | 351.3 |  |  | 350.2 |
Dilutive effect of stock options, RSUs and other |  | — |  |  | — |  |  | 1.6 |
Diluted weighted-average number of common shares outstanding |  | 352.1 |  |  | 351.3 |  |  | 351.8 |
(Loss) earnings per share attributable to Bausch Health Companies Inc. |  |  |  |  |  |
Basic |  | $ | (5.08 | ) |  | $ | (11.81 | ) |  | $ | 6.86 |
Diluted |  | $ | (5.08 | ) |  | $ | (11.81 | ) |  | $ | 6.83 |
In 2019 and 2018, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 5,106,000 and 3,763,000 common shares for 2019 and 2018, respectively. Additionally, in 2019, 2018 and 2017, stock options, time-based RSUs and performance-based RSUs to purchase approximately 2,598,000, 4,185,000 and 7,050,000 common shares of the Company, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration